Paul Lee is the CEO at Synesis One. Paul is a clinician, scientist, and entrepreneur. As a graduate of the University of Oxford with a degree in Molecular and Cellular Biochemistry, he received an M.D. from The School of Medicine at the Catholic University of Korea. Paul is also a graduate of Futuremed at Singularity University 2013 and Exponential Medicine 2014. Paul also co-founded JNP LAB in Seoul, which acts as a development hub for global exponential technologies.